Lifeline Biotechnologies Inc.
of Reno said it completed an agreement with a distributor for the Middle East, New Horizon Investment and Development of Cairo.
New Horizon is required in the next four years to post at least $1.1 million in sales of a Lifeline product that allows for examination of the interior of ducts of women's breasts.
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment